Description:

Study part: Status of treatment blind. A phase 1 single-masked, randomized (with respect to placebo), placebo-controlled, parallel-group, dose-rising study to evaluate the safety, tolerability and pharmacokinetics of repeat oral doses of GW786034 in elderly healthy volunteers. Trade Name: Votrient. Clinical Study ID: MD1103367.

Keywords:
  1. 6/19/18 6/19/18 -
  2. 9/20/21 9/20/21 -
Copyright Holder:
GlaxoSmithKline
Uploaded on:

September 20, 2021

DOI:
To request one please log in.
License :
Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Status of treatment blind Pazopanib Macular Degeneration MD1103367

Status of treatment blind

STATUS OF TREATMENT BLIND (Blind)
Was the treatment blind broken during the study?
Reason blind broken

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial